The chronic disease with the highest number of patients last year was hypertension.
Furthermore, malignant neoplasm (malignant tumors such as carcinoma and sarcoma) cost the most for national health insurance among the chronic disease.
According to the data released by the Health Insurance Review & Assessment Service (excluding oriental medical hospital and pharmacy), chronic disease with the highest number of patients over the past year was hypertension with 6,710,671 (about 6.71 million patients).
After hypertension, with 4,783,878 (about 4.78 million), arthritis was the highest, followed by mental and behavioral disorders with 3,455,435 (about 3.45 million).
More than 3 million people were treated for diabetes (3,334,989) and neurological disorders (3,212,945).
In addition, liver disease (1,859,762), malignant neoplasm (1,716,301), heart disease (1,630,419), thyroid disorder (1,432,277), and cerebrovascular disease (1,050,577) were in order.
The number of patients with chronic renal failure was 251,116, and the lowest number was respiratory tuberculosis with 41,309.
Meanwhile, chronic disease with the highest cost of national health insurance was malignant neoplasm (about 7.7478 trillion won.)
It is nearly twice as much as the mental and behavior disorder (3.9736 trillion won), which had the second-highest cost of insurance benefit.
The national health insurance for cerebrovascular disease was (2.7497 trillion won), neurological disorder (2.5085 trillion won,) chronic renal failure (2.1148 trillion won), arthritis (2.11 trillion won), and heart disease (2.747 trillion won).
Hypertension was estimated at 1.958 trillion won.
Diabetes (963.8 billion won), liver disease (650.5 billion won), thyroid disorder (256 billion won), and respiratory tuberculosis (120.4 billion won) were below 1 trillion won.
Among the 12 chronic diseases analyzed, chronic renal failure had the lowest number of patients after respiratory tuberculosis, but the cost of insurance benefit was the fifth highest.
